| Literature DB >> 1701369 |
R K Iles1, C L Lee, R T Oliver, T Chard.
Abstract
Ectopic-hCG production occurs in approximately 30% of urothelial cancers. However, the clinical features which might be expected to result from elevated hCG levels are rare. We now show that in six of seven metastatic and 20 of 21 localized (Ta-T4) positive hCG bladder cancer patients, only the free beta-subunit of hCG and its respective urinary breakdown product, beta-core, could be detected in clinical samples. Since only intact hCG is biologically active, this explains the discrepancy between biochemical and clinical findings.Entities:
Mesh:
Substances:
Year: 1990 PMID: 1701369 DOI: 10.1111/j.1365-2265.1990.tb00500.x
Source DB: PubMed Journal: Clin Endocrinol (Oxf) ISSN: 0300-0664 Impact factor: 3.478